Patent details

EP3600433 Title: AN AGENT THAT INCREASES THE EXPRESSSION OF THE BCL2-ASSOCIATED AGONIST OF CELL DEATH FOR THE TREATMENT OF CANCER

Basic Information

Publication number:
EP3600433
PCT Application Number:
GB2018050843
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP187171087
PCT Publication Number:
WO2018178690
First applicant's nationality:
Translation Language:
EPO Publication Language:
English Title of Invention:
AN AGENT THAT INCREASES THE EXPRESSSION OF THE BCL2-ASSOCIATED AGONIST OF CELL DEATH FOR THE TREATMENT OF CANCER
French Title of Invention:
AGENT AUGMENTANT L'EXPRESSION DE L'AGONISTE DE LA MORT CELLULAIRE ASSOCIÉ À BCL2 POUR LE TRAITEMENT DU CANCER
German Title of Invention:
MITTEL ZUR ERHÖHUNG DER EXPRESSION DES BCL2-ASSOZIIERTEN AGONISTEN DES ZELLTODS ZUR BEHANDLUNG VON KREBS
SPC Number:

Dates

Filing date:
28/03/2018
Grant date:
05/05/2021
EP Publication Date:
05/02/2020
PCT Publication Date:
04/10/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
05/05/2021
EP B1 Publication Date:
05/05/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
28/03/2022
Expiration date:
28/03/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
28/04/2021
 
 

Name:
LDN Pharma Limited
Address:
25 Moorgate, London, EC2R 6AY, United Kingdom (GB)

Inventor

1

Name:
LUI, Wai
Address:
United Kingdom (GB)

2

Name:
DALGLEISH, Angus
Address:
United Kingdom (GB)

Priority

1

Priority Number:
201704910
Priority Date:
28/03/2017
Priority Country:
United Kingdom (GB)

2

Priority Number:
201718806
Priority Date:
14/11/2017
Priority Country:
United Kingdom (GB)

Classification

IPC classification:
A61K 31/485; A61K 31/555; A61K 31/675; A61K 31/7068; A61K 45/06; A61P 35/00; G01N 33/50;

Publication

European Patent Bulletin

Issue number:
202118
Publication date:
05/05/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages